期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 332, 期 1, 页码 135-141出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2005.04.098
关键词
stem cells; TGF-beta 2; embryoid body; cardiac myocytes; heart
Stem cell therapy holds great promise for the treatment of injured myocardium, but is challenged by a limited supply of appropriate cells. Three different isoforms of transforming growth factor-beta (TGF-beta) -beta 1, -beta 2, and -beta 3 exhibit distinct regulatory effects on cell growth, differentiation, and migration during embryonic development. We compared the effects of these three different isoforms on cardiomyocyte differentiation front embryonic stem (ES) cells. In contrast to TGF-beta 1, or -beta 3, treatment of mouse ES cells with TGF-beta 2 isoform significantly increased embryoid body (EB) proliferation as well as the extent of the EB outgrowth that beat rhythmically. At 17 days, 49 % of the EBs treated with TGF-beta 2 exhibited spontaneous beating compared with 15 % in controls. Cardiac myocyte specific protein markers sarcomeric myosin and alpha-actin were demonstrated in beating EBs and cells isolated from EBs. In conclusion, TGF-beta 2 but not TGF-beta 1, or -beta 3 promotes cardiac myocyte differentiation from ES cells. (c) 2005 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据